Objective
Seeks long-term capital appreciation.
Overview
A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.
The Health-Care Revolution
The health-care sector is undergoing dramatic changes that will impact everything from the drugs we take to the way patients’ medical records are shared. Aging demographics globally and rising prosperity in emerging-market nations will drive even greater demand for lifesaving drugs, innovative procedures, and disruptive medical technology.
Pipeline to Innovation
With innovation and breakthroughs taking place across the globe, the Fund uses a broadly diversified, global approach that seeks to identify companies with the greatest opportunities in areas including biotechnology, medical technology, health services, and pharmaceuticals.
Backed by Size, Scale, and Experience
Wellington Management, the Fund’s sub-adviser, is one of the largest managers of health care stocks in the world. The portfolio managers on the Fund average 26 years of experience.
|
Average Annual Total Returns % (as of 2/29/2020)
|
|||||
| 1YR | 5YR | 10YR | SI | ||
|---|---|---|---|---|---|
| Hartford Healthcare I | 10.35 | 7.30 | 14.73 | 11.53 | |
| Benchmark | 3.22 | 7.37 | 13.98 | --- | |
| Morningstar Health Category | 4.21 | 5.33 | 14.03 | --- | |
|
Average Annual Total Returns % (as of 12/31/2019)
|
|||||
| 1YR | 5YR | 10YR | SI | ||
|---|---|---|---|---|---|
| Hartford Healthcare I | 33.69 | 10.42 | 15.76 | 12.03 | |
| Benchmark | 20.87 | 10.69 | 15.17 | --- | |
| Morningstar Health Category | 26.10 | 8.58 | 15.05 | --- | |
SI = Since Inception.
Fund Inception: 05/01/2000
Share Class Inception: 8/31/06.Class I-share performance prior to its inception date reflects Class A-share performance (excluding sales charges) and operating expenses. SI performance is calculated from 5/1/00.
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
Growth of $10,000 (I-Share)
(as of 2/29/2020)[{"date":"Sat Feb 29 00:00:00 EST 2020","value":"39523.0"},{"date":"Fri Jan 31 00:00:00 EST 2020","value":"41601.0"},{"date":"Tue Dec 31 00:00:00 EST 2019","value":"42428.0"},{"date":"Sat Nov 30 00:00:00 EST 2019","value":"40626.0"},{"date":"Thu Oct 31 00:00:00 EDT 2019","value":"37677.0"},{"date":"Mon Sep 30 00:00:00 EDT 2019","value":"35487.0"},{"date":"Sat Aug 31 00:00:00 EDT 2019","value":"36087.0"},{"date":"Wed Jul 31 00:00:00 EDT 2019","value":"36627.0"},{"date":"Sun Jun 30 00:00:00 EDT 2019","value":"36767.0"},{"date":"Fri May 31 00:00:00 EDT 2019","value":"34227.0"},{"date":"Tue Apr 30 00:00:00 EDT 2019","value":"35417.0"},{"date":"Sun Mar 31 00:00:00 EDT 2019","value":"36227.0"},{"date":"Thu Feb 28 00:00:00 EST 2019","value":"35817.0"},{"date":"Thu Jan 31 00:00:00 EST 2019","value":"34797.0"},{"date":"Mon Dec 31 00:00:00 EST 2018","value":"31737.0"},{"date":"Fri Nov 30 00:00:00 EST 2018","value":"35112.0"},{"date":"Wed Oct 31 00:00:00 EDT 2018","value":"33533.0"},{"date":"Sun Sep 30 00:00:00 EDT 2018","value":"37619.0"},{"date":"Fri Aug 31 00:00:00 EDT 2018","value":"37601.0"},{"date":"Tue Jul 31 00:00:00 EDT 2018","value":"35901.0"},{"date":"Sat Jun 30 00:00:00 EDT 2018","value":"34425.0"},{"date":"Thu May 31 00:00:00 EDT 2018","value":"34453.0"},{"date":"Mon Apr 30 00:00:00 EDT 2018","value":"32920.0"},{"date":"Sat Mar 31 00:00:00 EDT 2018","value":"33162.0"},{"date":"Wed Feb 28 00:00:00 EST 2018","value":"33524.0"},{"date":"Wed Jan 31 00:00:00 EST 2018","value":"34815.0"},{"date":"Sun Dec 31 00:00:00 EST 2017","value":"32633.0"},{"date":"Thu Nov 30 00:00:00 EST 2017","value":"32772.0"},{"date":"Tue Oct 31 00:00:00 EDT 2017","value":"32198.0"},{"date":"Sat Sep 30 00:00:00 EDT 2017","value":"33117.0"},{"date":"Thu Aug 31 00:00:00 EDT 2017","value":"33037.0"},{"date":"Mon Jul 31 00:00:00 EDT 2017","value":"32701.0"},{"date":"Fri Jun 30 00:00:00 EDT 2017","value":"32622.0"},{"date":"Wed May 31 00:00:00 EDT 2017","value":"30890.0"},{"date":"Sun Apr 30 00:00:00 EDT 2017","value":"30625.0"},{"date":"Fri Mar 31 00:00:00 EDT 2017","value":"30165.0"},{"date":"Tue Feb 28 00:00:00 EST 2017","value":"30015.0"},{"date":"Tue Jan 31 00:00:00 EST 2017","value":"28026.0"},{"date":"Sat Dec 31 00:00:00 EST 2016","value":"26762.0"},{"date":"Wed Nov 30 00:00:00 EST 2016","value":"26533.0"},{"date":"Mon Oct 31 00:00:00 EDT 2016","value":"25842.0"},{"date":"Fri Sep 30 00:00:00 EDT 2016","value":"28117.0"},{"date":"Wed Aug 31 00:00:00 EDT 2016","value":"27578.0"},{"date":"Sun Jul 31 00:00:00 EDT 2016","value":"28985.0"},{"date":"Thu Jun 30 00:00:00 EDT 2016","value":"27369.0"},{"date":"Tue May 31 00:00:00 EDT 2016","value":"27241.0"},{"date":"Sat Apr 30 00:00:00 EDT 2016","value":"26325.0"},{"date":"Thu Mar 31 00:00:00 EDT 2016","value":"25569.0"},{"date":"Mon Feb 29 00:00:00 EST 2016","value":"24854.0"},{"date":"Sun Jan 31 00:00:00 EST 2016","value":"25392.0"},{"date":"Thu Dec 31 00:00:00 EST 2015","value":"29194.0"},{"date":"Mon Nov 30 00:00:00 EST 2015","value":"29062.0"},{"date":"Sat Oct 31 00:00:00 EDT 2015","value":"28045.0"},{"date":"Wed Sep 30 00:00:00 EDT 2015","value":"26278.0"},{"date":"Mon Aug 31 00:00:00 EDT 2015","value":"28613.0"},{"date":"Fri Jul 31 00:00:00 EDT 2015","value":"30774.0"},{"date":"Tue Jun 30 00:00:00 EDT 2015","value":"29785.0"},{"date":"Sun May 31 00:00:00 EDT 2015","value":"29462.0"},{"date":"Thu Apr 30 00:00:00 EDT 2015","value":"27674.0"},{"date":"Tue Mar 31 00:00:00 EDT 2015","value":"28312.0"},{"date":"Sat Feb 28 00:00:00 EST 2015","value":"27793.0"},{"date":"Sat Jan 31 00:00:00 EST 2015","value":"26600.0"},{"date":"Wed Dec 31 00:00:00 EST 2014","value":"25843.0"},{"date":"Sun Nov 30 00:00:00 EST 2014","value":"25607.0"},{"date":"Fri Oct 31 00:00:00 EDT 2014","value":"24708.0"},{"date":"Tue Sep 30 00:00:00 EDT 2014","value":"23139.0"},{"date":"Sun Aug 31 00:00:00 EDT 2014","value":"23414.0"},{"date":"Thu Jul 31 00:00:00 EDT 2014","value":"22449.0"},{"date":"Mon Jun 30 00:00:00 EDT 2014","value":"22823.0"},{"date":"Sat May 31 00:00:00 EDT 2014","value":"21937.0"},{"date":"Wed Apr 30 00:00:00 EDT 2014","value":"21208.0"},{"date":"Mon Mar 31 00:00:00 EDT 2014","value":"21865.0"},{"date":"Fri Feb 28 00:00:00 EST 2014","value":"22587.0"},{"date":"Fri Jan 31 00:00:00 EST 2014","value":"21182.0"},{"date":"Tue Dec 31 00:00:00 EST 2013","value":"20381.0"},{"date":"Sat Nov 30 00:00:00 EST 2013","value":"19947.0"},{"date":"Thu Oct 31 00:00:00 EDT 2013","value":"18884.0"},{"date":"Mon Sep 30 00:00:00 EDT 2013","value":"18234.0"},{"date":"Sat Aug 31 00:00:00 EDT 2013","value":"17498.0"},{"date":"Wed Jul 31 00:00:00 EDT 2013","value":"17840.0"},{"date":"Sun Jun 30 00:00:00 EDT 2013","value":"16546.0"},{"date":"Fri May 31 00:00:00 EDT 2013","value":"16697.0"},{"date":"Tue Apr 30 00:00:00 EDT 2013","value":"16349.0"},{"date":"Sun Mar 31 00:00:00 EDT 2013","value":"15765.0"},{"date":"Thu Feb 28 00:00:00 EST 2013","value":"14826.0"},{"date":"Thu Jan 31 00:00:00 EST 2013","value":"14649.0"},{"date":"Mon Dec 31 00:00:00 EST 2012","value":"13592.0"},{"date":"Fri Nov 30 00:00:00 EST 2012","value":"13572.0"},{"date":"Wed Oct 31 00:00:00 EDT 2012","value":"13493.0"},{"date":"Sun Sep 30 00:00:00 EDT 2012","value":"13808.0"},{"date":"Fri Aug 31 00:00:00 EDT 2012","value":"13204.0"},{"date":"Tue Jul 31 00:00:00 EDT 2012","value":"13106.0"},{"date":"Sat Jun 30 00:00:00 EDT 2012","value":"13152.0"},{"date":"Thu May 31 00:00:00 EDT 2012","value":"12495.0"},{"date":"Mon Apr 30 00:00:00 EDT 2012","value":"12935.0"},{"date":"Sat Mar 31 00:00:00 EDT 2012","value":"12961.0"},{"date":"Wed Feb 29 00:00:00 EST 2012","value":"12324.0"},{"date":"Tue Jan 31 00:00:00 EST 2012","value":"12121.0"},{"date":"Sat Dec 31 00:00:00 EST 2011","value":"11313.0"},{"date":"Wed Nov 30 00:00:00 EST 2011","value":"11156.0"},{"date":"Mon Oct 31 00:00:00 EDT 2011","value":"11228.0"},{"date":"Fri Sep 30 00:00:00 EDT 2011","value":"10538.0"},{"date":"Wed Aug 31 00:00:00 EDT 2011","value":"11241.0"},{"date":"Sun Jul 31 00:00:00 EDT 2011","value":"11766.0"},{"date":"Thu Jun 30 00:00:00 EDT 2011","value":"12377.0"},{"date":"Tue May 31 00:00:00 EDT 2011","value":"12561.0"},{"date":"Sat Apr 30 00:00:00 EDT 2011","value":"12088.0"},{"date":"Thu Mar 31 00:00:00 EDT 2011","value":"11359.0"},{"date":"Mon Feb 28 00:00:00 EST 2011","value":"11011.0"},{"date":"Mon Jan 31 00:00:00 EST 2011","value":"10703.0"},{"date":"Fri Dec 31 00:00:00 EST 2010","value":"10473.0"},{"date":"Tue Nov 30 00:00:00 EST 2010","value":"9888.0"},{"date":"Sun Oct 31 00:00:00 EDT 2010","value":"10138.0"},{"date":"Thu Sep 30 00:00:00 EDT 2010","value":"9993.0"},{"date":"Tue Aug 31 00:00:00 EDT 2010","value":"9015.0"},{"date":"Sat Jul 31 00:00:00 EDT 2010","value":"9317.0"},{"date":"Wed Jun 30 00:00:00 EDT 2010","value":"9186.0"},{"date":"Mon May 31 00:00:00 EDT 2010","value":"9573.0"},{"date":"Fri Apr 30 00:00:00 EDT 2010","value":"10177.0"},{"date":"Wed Mar 31 00:00:00 EDT 2010","value":"10584.0"},{"date":"Sun Feb 28 00:00:00 EST 2010","value":"10000.0"}]
(as of 2/29/2020)
-
Overall
:
Overall, 4 stars, 3-Year, 3 stars, 5-Year, 4 stars, and 10-Year, 4 stars, rated against 136, 136, 125 and 104 products, respectively. Morningstar RatingTM is calculated for products with at least a 3-year history, based on a risk-adjusted return measure (excluding any applicable sale charges) and accounts for variations in a product's monthly performance. 5 stars are assigned to the top 10%; 4 stars to the next 22.5%, 3 stars to the next 35%, 2 stars to the next 22.5% and 1 star to the bottom 10%. ETFs and mutual funds are considered a single population. The Overall Rating is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. For more information about these ratings, including their methodology, please go to global.morningstar.com/managerdisclosures. Ratings for other share classes may vary and are subject to change monthly. Past performance is no guarantee of future performance.
©2020 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.:
- 136 Products | Health Category
| Fund | BENCHMARK | |
|---|---|---|
| 2019 | 33.69 | 20.87 |
| 2018 | -2.74 | 6.71 |
| 2017 | 21.94 | 22.47 |
| 2016 | -8.33 | -2.05 |
| 2015 | 12.97 | 7.41 |
| 2014 | 26.80 | 24.79 |
| 2013 | 49.95 | 42.19 |
| 2012 | 20.14 | 18.35 |
| 2011 | 8.03 | 11.88 |
| 2010 | 6.69 | 5.20 |
Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.
CharacteristicsAllocations, exposures and holdings are subject to change. Percentages may be rounded.
Allocations, exposures and holdings are subject to change. Percentages may be rounded.
| As of Date | 2/29/2020 |
| Net Assets | $1.3 billion |
| # of Holdings | 107 |
| % in Equities | 98 |
| % in Foreign Equities | 17 |
| Beta (3 year) | 1.05 |
| R Squared (3 year) | 0.85 |
| Standard Deviation | 15.52% |
| Turnover (12/31/2019) | 42% |
| Active Share | 58% |
| Fund | S&P Composite 1500 Health Care Index | |
|---|---|---|
| Price/Earnings | 39.5x | 14.8x |
| Price/Book | 4.1x | 4.2x |
| EPS Growth Rate | 12.1% | 10.0% |
| Return on Equity | 2.2% | 22.0% |
| Asset Weighted Market Cap (billions) | $61.9 | $121.9 |
| Median Market Cap (billions) | $4.0 | $3.7 |
| Fund | |
|---|---|
| Alpha (5 Year) | -0.48 |
| Down Capture (5 Year) | 111.72 |
| Information Ratio (5 Year) | -0.01 |
| Sharpe Ratio (5 Year) | 0.44 |
| Up Capture (5 Year) | 108.01 |
| Fund | |
|---|---|
| Less than $2 billion | 12 |
| $2 billion - $5 billion | 15 |
| $5 billion - $10 billion | 8 |
| Greater than $10 billion | 65 |
| Not Classified | 0 |
Regional Exposure (%)
| label | value |
|---|---|
| North America | 82 |
| Europe | 11 |
| Japan | 4 |
| Emerging Markets | 3 |
| Middle East/Developed | 1 |
| label | value |
|---|---|
| North America | 82 |
| Europe | 11 |
| Japan | 4 |
| Emerging Markets | 3 |
| Middle East/Developed | 1 |
Top Ten Holdings (%)
| label | percentageholding |
|---|---|
| Pfizer, Inc. | 5.02 |
| Bristol-Myers Squibb Co. | 4.24 |
| Abbott Laboratories | 4.19 |
| Medtronic plc | 3.85 |
| Eli Lilly & Co. | 3.60 |
| Thermo Fisher Scientific, Inc. | 3.41 |
| UnitedHealth Group, Inc. | 2.87 |
| Boston Scientific Corp. | 2.85 |
| Danaher Corp. | 2.65 |
| AstraZeneca plc | 2.55 |
| Total Portfolio % | 35.23 |
| label | percentageholding |
|---|---|
| Pfizer, Inc. | 5.45 |
| Abbott Laboratories | 4.49 |
| Bristol-Myers Squibb Co. | 4.36 |
| Medtronic plc | 4.12 |
| Thermo Fisher Scientific, Inc. | 3.60 |
| Eli Lilly & Co. | 3.56 |
| Boston Scientific Corp. | 3.28 |
| UnitedHealth Group, Inc. | 3.15 |
| Anthem, Inc. | 2.84 |
| AstraZeneca plc | 2.76 |
| Total Portfolio % | 37.61 |
| Inception Date | 05/01/2000 |
| Symbol | HGHIX |
| CUSIP | 416649887 |
| Fund Number | 1309 |
Subsector Exposure
| label | currentpercentage |
|---|---|
| Medical Technology | 30 |
| Biopharma Large Cap | 23 |
| Biopharma Mid Cap | 17 |
| Health Care Services | 17 |
| Biopharma Small Cap | 12 |
| label | currentpercentage |
|---|---|
| Medical Technology | 29 |
| Biopharma Large Cap | 23 |
| Biopharma Mid Cap | 18 |
| Health Care Services | 20 |
| Biopharma Small Cap | 9 |
Based on sub-adviser's classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.
The Future of Healthcare
12/04/2019Medical technology innovations are disrupting traditional markets and changing the way providers and patients approach healthcare.
Investable Innovation: Tracking Remarkable Biopharmaceutical Advances
05/07/2019In the coming decade, we should witness the arrival of a host of wonderful new drugs and novel treatment modalities.
Financial Professionals:
Log in to order forms and literature and manage your subscriptions.
-
Add to favorite(0) -
Email(0) -
Add to Cart(0)
Fund LiteratureSelect All
0 items Selected
|
Fact Sheet12/31/2019 | pdfThis client flyer summarizes the Fund's investment approach, portfolio statistics, top holdings, and current performance. |
Fund Story03/25/2020 | pdfThis Fund Story outlines three distinguishing characteristics to help investors better understand the Fund. |
Commentary12/31/2019 | pdfCurrent quarterly commentary from our sub-adviser, Wellington Management, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund. |
Expanded Commentary12/31/2019 | pdfCurrent quarterly commentary from our sub-adviser, Wellington Management, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund.
|
Summary Prospectus02/28/2020 | pdfA concise summary of the Fund’s investment strategy, performance, expenses, risks, and management team.
|
Healthcare Fund Pitchbook12/31/2019 | pdfThis Pitchbook reviews the Funds' investment approach, investment team, investment process, and general portfolio parameters.
|
Semi Annual Report04/30/2019 | pdfA semi-annual update on the Fund that includes a manager discussion of the Fund’s performance and financial statements.
|
Statutory Prospectus02/28/2020 | pdfAn annual update on the Fund that includes information about the Fund’s investment manager, sub-adviser, and operations.
|
Annual Report10/31/2019 | pdfAn annual update on the Fund that includes a manager discussion of the Fund’s performance and financial statements.
|
SAI02/28/2020 | pdfA supplementary document to the Fund’s prospectus that includes additional information about the Fund and its operations.
|
Important Risks: Investing involves risk, including the possible loss of principal. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political and economic developments. These risks may be greater for investments in emerging markets.
212244 210715